Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia.
Shanshan NieYuhang ZhaoZeying FengChan ZouFangfang DingLiying GongHongwei LuYu CaoGuo-Ping YangPublished in: Clinical drug investigation (2024)
Hyperuricemia was independently related to an increased risk of all-cause and cardiovascular death in patients with ACS undergoing PCI. At 1-year follow-up, there were no significant differences between ticagrelor and clopidogrel concerning all-cause and cardiovascular death in patients with hyperuricemia.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- uric acid
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- cardiovascular events
- heart failure
- type diabetes
- risk factors
- cardiovascular disease
- coronary artery disease
- coronary artery bypass
- left ventricular